FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

17845911000001103: Irinotecan 40mg/2ml concentrate for solution for infusion vials (Hospira UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 22-Sep 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
61401601000001117 Irinotecan 40mg/2ml concentrate for solution for infusion vials (Hospira UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
106080801000001119 Irinotecan 40mg/2ml concentrate for solution for infusion vials (Pfizer Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Irinotecan 40mg/2ml concentrate for solution for infusion vials (Hospira UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Irinotecan 40mg/2ml concentrate for solution for infusion vials (Hospira UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction hospital only true Inferred relationship Existential restriction modifier
Irinotecan 40mg/2ml concentrate for solution for infusion vials (Hospira UK Ltd) Is a Irinotecan hydrochloride trihydrate 20mg/mL infusion concentrate 2mL vial false Inferred relationship Existential restriction modifier
Irinotecan 40mg/2ml concentrate for solution for infusion vials (Hospira UK Ltd) Has active ingredient Irinotecan hydrochloride true Inferred relationship Existential restriction modifier
Irinotecan 40mg/2ml concentrate for solution for infusion vials (Hospira UK Ltd) Has manufactured dose form Infusion concentrate false Inferred relationship Existential restriction modifier
Irinotecan 40mg/2ml concentrate for solution for infusion vials (Hospira UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Irinotecan 40mg/2ml concentrate for solution for infusion vials (Hospira UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Irinotecan 40mg/2ml concentrate for solution for infusion vials (Hospira UK Ltd) Has specific active ingredient Irinotecan hydrochloride trihydrate false Inferred relationship Existential restriction modifier
Irinotecan 40mg/2ml concentrate for solution for infusion vials (Hospira UK Ltd) Has dispensed dose form Conventional release solution for infusion true Inferred relationship Existential restriction modifier
Irinotecan 40mg/2ml concentrate for solution for infusion vials (Hospira UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Irinotecan 40mg/2ml concentrate for solution for infusion vials (Hospira UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Irinotecan 40mg/2ml concentrate for solution for infusion vials (Hospira UK Ltd) Has specific active ingredient Irinotecan hydrochloride trihydrate true Inferred relationship Existential restriction modifier
Irinotecan 40mg/2ml concentrate for solution for infusion vials (Hospira UK Ltd) Is a Irinotecan 40mg/2ml solution for infusion vials false Inferred relationship Existential restriction modifier
Irinotecan 40mg/2ml concentrate for solution for infusion vials (Hospira UK Ltd) Is a Irinotecan 40mg/2ml solution for infusion vials true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Irinotecan 40mg/2ml concentrate for solution for infusion vials (Hospira UK Ltd) 1 vial Has AMP True Irinotecan 40mg/2ml concentrate for solution for infusion vials (Hospira UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start